EP0958304A4 - Sequence nucleotidique codant la proteine de type cd33 - Google Patents

Sequence nucleotidique codant la proteine de type cd33

Info

Publication number
EP0958304A4
EP0958304A4 EP96928838A EP96928838A EP0958304A4 EP 0958304 A4 EP0958304 A4 EP 0958304A4 EP 96928838 A EP96928838 A EP 96928838A EP 96928838 A EP96928838 A EP 96928838A EP 0958304 A4 EP0958304 A4 EP 0958304A4
Authority
EP
European Patent Office
Prior art keywords
protein
nucleotide sequence
sequence encoding
encoding
nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96928838A
Other languages
German (de)
English (en)
Other versions
EP0958304A1 (fr
Inventor
Jian Ni
Reiner L Gentz
Craig A Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0958304A1 publication Critical patent/EP0958304A1/fr
Publication of EP0958304A4 publication Critical patent/EP0958304A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP96928838A 1996-08-09 1996-08-09 Sequence nucleotidique codant la proteine de type cd33 Withdrawn EP0958304A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/013007 WO1998006733A1 (fr) 1996-08-09 1996-08-09 Sequence nucleotidique codant la proteine de type cd33

Publications (2)

Publication Number Publication Date
EP0958304A1 EP0958304A1 (fr) 1999-11-24
EP0958304A4 true EP0958304A4 (fr) 2002-01-16

Family

ID=22255589

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96928838A Withdrawn EP0958304A4 (fr) 1996-08-09 1996-08-09 Sequence nucleotidique codant la proteine de type cd33

Country Status (4)

Country Link
EP (1) EP0958304A4 (fr)
JP (1) JP2001502888A (fr)
AU (1) AU6844596A (fr)
WO (1) WO1998006733A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998053840A1 (fr) * 1997-05-27 1998-12-03 Smithkline Beecham Corporation Adnc de la famille des sialoadhesines 4 (saf-4)
WO2001012646A1 (fr) * 1999-08-19 2001-02-22 Smithkline Beecham Corporation Anticorps d'agonistes et d'antagonistes de sialoadhesine facteur-1
EP2037966A2 (fr) 2006-05-11 2009-03-25 Ghent University Compositions associées à la sialoadhésine et procédés correspondants
AU2007317333A1 (en) * 2006-11-02 2008-05-15 Seattle Genetics, Inc. Methods of treating neoplastic, autoimmune and inflammatory diseases
US10479832B2 (en) 2014-03-31 2019-11-19 Universiteit Gent Method of treating bone disease

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
A. L. CORNISH ET AL.: "CHARACTERISATION OF SIGLEC-5, A NOVEL GLYCOPROTEIN EXPRESSED ON MYELOID CELLS RELATED TO CD33", BLOOD, vol. 92, no. 6, 15 September 1998 (1998-09-15), pages 2123 - 2132, XP000913901 *
CRECKER ET AL: "Sialoadhesin and related cellular recognition molecules of the immunoglobulin superfamily", BIOCHEMICAL SOCIETY TRANSACTIONS, vol. 24, February 1996 (1996-02-01), pages 150 - 156, XP000913910 *
CROCKER ET AL: "Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin-like domains", EMBO JOURNAL, vol. 13, no. 19, pages 4490 - 4503, XP002911957 *
D. SIMMONS ET AL.: "ISOLATION OF A cDNA ENCODING CD33, A DIFFERENTIATION ANTIGEN OF MYELOID PROGENITOR CELLS", JOURNAL OF IMMUNOLOGY, vol. 141, no. 8, 15 October 1988 (1988-10-15), pages 2797 - 2800, XP002072092 *
ERICKSON-MILLER: "Characterization of Siglec-5 (CD170) expression and functional activity of anti-Siglec-5 antibodies on human phagocytes", vol. 31, 2002, pages 382 - 388 *
FREEMAN ET AL: "CHARACTERIZATION OF CD33 AS A NEW MEMBER OF THE SIALOADHESIN FAMILY OF CELLULAR INTERACTION MOLECULES", BLOOD, vol. 85, no. 8, 15 April 1995 (1995-04-15), pages 2005 - 2012 *
KELM S. ET AL: "The Sialoadhesins - A family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily", GLYCOCONJUGATE JOURNAL, vol. 13, December 1996 (1996-12-01), pages 913 - 926 *
See also references of WO9806733A1 *

Also Published As

Publication number Publication date
AU6844596A (en) 1998-03-06
WO1998006733A1 (fr) 1998-02-19
JP2001502888A (ja) 2001-03-06
EP0958304A1 (fr) 1999-11-24

Similar Documents

Publication Publication Date Title
IL134480A0 (en) Kay - an immune system protein and dna sequences encoding the same
PT1490386E (pt) Novos polipéptidos e ácidos nucleicos que os codificam
ZA979996B (en) Protein purification
ZA9710288B (en) Novel genes encoding telomerase proteins.
ZA9710338B (en) Proteins
GB9703681D0 (en) Protein complemention
GB9719879D0 (en) Protein
EP1018551A4 (fr) Proteine megsine
EP0763046A4 (fr) Adn codant pour le gene 1 de synthese du glucane
ZA972186B (en) Lytic peptides.
GB9421093D0 (en) Hippocampus-associated proteins, DNA sequences coding therefore and uses thereof
PL340374A1 (en) Tanatin encoding gene
EP0958304A4 (fr) Sequence nucleotidique codant la proteine de type cd33
EP0729975A4 (fr) Proteine ecdn et adn codant cette proteine
GB9720784D0 (en) Protein
GB0107378D0 (en) Sequence encoding CYSDV coat protein
EP0915100A4 (fr) Nouvelle proteine
IL137823A0 (en) Novel polypeptides and nucleic acids encoding the same
GB9604865D0 (en) Modified proteins
ZA973709B (en) Proteins.
EP0960198A4 (fr) Proteine de type cd44
GB9422021D0 (en) Macrophone nucleotide sequence
GB9707599D0 (en) Proteins
GB9607689D0 (en) Proteins
ZA9811071B (en) Polypeptides and nucleic acids encoding the same.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990309

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20011203

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20031106

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070301